Friday, November 21, 2014

Top 5 Small Cap Stocks To Own Right Now

Small cap stocks Greenfield Farms Food Inc (OTCMKTS: GRAS), International Stem Cell Corp (OTCMKTS: ISCO) and Redpoint Bio Corporation (OTCMKTS: RPBC) have all been getting some extra attention lately in various investment newsletters. However, none of these small cap stocks appear to have been the subject or paid promotions or investor relations activities. So does that make any of them good bets for traders and investors alike? Here is a quick look and a reality check:

Greenfield Farms Food Inc (OTCMKTS: GRAS) Expects Financing to Close in February

Small cap Greenfield Farms Food operates through its wholly-owned subsidiary Carmela's Pizzeria CO, Inc. through the Carmela's Pizzeria Dayton restaurant locations that include pizza buffets, alcohol service, delivery and carry-out depending on the location; and has previously been a limited producer and marketer of "grassfed" beef that supplied a North Carolina based grocer. On Monday, Greenfield Farms Food closed at $0.0033 for a market cap of $31,345 plus GRAS is up 230% since last October and down 99.4% since April 2011 according to Google Finance.

5 Best Mid Cap Stocks To Buy For 2015: bebe stores inc.(BEBE)

bebe stores, inc. engages in the design, development, and production of women?s apparel and accessories. Its products include a range of separates, tops, dresses, active wear, and accessories in career, evening, casual, and active lifestyle categories. The company markets its products under the bebe, BEBE SPORT, bbsp, and 2b bebe brand names targeting 21 to 34-year-old woman. As of July 2, 2011, it operated 252 retail stores, and an online store at bebe.com in the United States, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, Japan, and Canada, as well as 60 international licensee operated stores in south east Asia, the United Arab Emirates, Israel, Russia, Mexico, and Turkey. The company was founded in 1976 and is headquartered in Brisbane, California.

Advisors' Opinion:
  • [By Monica Gerson]

    Bebe Stores (NASDAQ: BEBE) is estimated to post a Q4 loss at $0.17 per share on revenue of $104.79 million.

    UTi Worldwide (NASDAQ: UTIW) is expected to report its Q2 earnings at $0.01 per share on revenue of $1.14 billion.

Top 5 Small Cap Stocks To Own Right Now: FuelCell Energy Inc.(FCEL)

FuelCell Energy, Inc., together with its subsidiaries, engages in the development, manufacturing, and sale of high temperature fuel cells for clean electric power generation primarily in South Korea, the United States, Germany, Canada, and Japan. The company offers proprietary carbonate Direct FuelCell Power Plants that electrochemically produce electricity from hydrocarbon fuels, such as natural gas and biogas. Its fuel cells operate on a range of hydrocarbon fuels, including natural gas, renewable biogas, propane, methanol, coal gas, and coal mine methane. The company also develops carbonate fuel cells, planar solid oxide fuel cell technology, and other fuel cell technologies. It provides its products to universities; manufacturers; mission critical institutions, such as correction facilities and government installations; hotels; and natural gas letdown stations, as well as to customers who use renewable biogas for fuel, including municipal water treatment facilities, br eweries, and food processors. The company was founded in 1969 and is headquartered in Danbury, Connecticut.

Advisors' Opinion:
  • [By Dan Caplinger]

    FuelCell Energy (NASDAQ: FCEL  ) will release its quarterly report on Monday, and bullish investors have sent shares of this fuel-cell power-plant developer soaring in recent days as the space has drawn a lot of attention lately. With industry peer Plug Power (NASDAQ: PLUG  ) having made a deal with Wal-Mart to supply the retailer with fuel-cell power, Plug, Ballard Power Systems (NASDAQ: BLDP  ) , and FuelCell have all inspired dreams of huge growth in the near future.

  • [By Paul Ausick]

    The most heavily traded Nasdaq stock today is Plug Power Inc. (NASDAQ: PLUG). The fuel cell maker has been riding a wave of buying based on its deal with Wal-Mart Stores Inc. (NYSE: WMT). Today, however, competitor FuelCell Energy Inc. (NASDAQ: FCEL) announced an increase in a federal contract Plug Power is getting a big coattail effect. Shares are set to close up 29.89% at $8.26 in a 52-week range of $0.15 to $8.30 (a new 52-week high today). Share volume was approaching 5-times more than the daily average of around 26 million shares traded.

  • [By John Udovich]

    Small cap hydrogen fuel stocks Hydrogenics Corporation (NASDAQ: HYGS), FuelCell Energy Inc (NASDAQ: FCEL), HyperSolar Inc (OTCMKTS: HYSR) and HydroPhi Technologies Group, Inc (OTCMKTS: HPTG) are some of the lesser known small caps that are�working with hydrogen fuel or hydrogen fuel cell related technology. I should say that small cap hydrogen stocks are not for risk adverse investors as there are considerable unanswered questions about hydrogen fuel related technology and whether it can be a viable green technology given the fueling infrastructure needed along with the�energy and expense involved in creating hydrogen�(Note: None of these small cap�stocks are profitable at ). But any new technology will pose the same types of risks for early stage investors���especially if its so-called green technology.�

  • [By Ben Levisohn]

    Cowen’s Jeffrey Osborne and Thomas Boyes are impressed with Plug Power’s (PLUG) financial results, which are helping to boost Ballard Power Systems (BLDP) and FuelCell Energy (FCEL), as well:

Top 5 Small Cap Stocks To Own Right Now: ATA Inc.(ATAI)

ATA Inc., through its subsidiaries, provides computer-based testing services in the People?s Republic of China. It offers services for the creation and delivery of computer-based tests utilizing its test delivery platform, proprietary testing technologies, and testing services; and provides logistical support services relating to test administration. The company?s computer-based testing services are used for professional licensure and certification tests in various industries, including information technology (IT) services, banking, securities, teaching, and insurance. Its e-testing platform integrates various aspects of the test delivery process for computer-based tests ranging from test form compilation to test scoring, and results analysis. ATA also provides career-oriented educational services, such as single course programs, degree major course programs, and pre-occupational training programs focusing on preparing students to pass IT and other vocational certification tests; test preparation and training programs and services to test candidates preparing to take professional certification tests in securities, futures, banking, insurance and teaching industries; online test preparation and training platform for the securities and banking industries; and test preparation software for the teaching industry. In addition, the company offers HR select employee assessment solution, an online system that utilizes its proprietary software and an inventory of test titles to help employers improve the efficiency and accuracy of their employee recruitment process. As of March 31, 2010, it had contractual relationships with 1,988 ATA authorized test centers. The company serves Chinese governmental agencies, professional associations, IT vendors, and Chinese educational institutions, as well as individual test preparation services. ATA Inc. was founded in 1999 and is based in Beijing, the People?s Republic of China.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Industrials stocks gained Friday, with ATA (NASDAQ: ATAI) leading advancers. Meanwhile, gainers in the sector included Plug Power (NASDAQ: PLUG), with shares up 22 percent, and Korn/Ferry International (KFY), with shares up 12 percent. In trading on Friday, basic materials shares were relative laggards, down on the day by about 1.36 percent.

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Industrials stocks gained Friday, with ATA (NASDAQ: ATAI) leading advancers. Meanwhile, gainers in the sector included Plug Power (NASDAQ: PLUG), with shares up 22 percent, and Korn/Ferry International (KFY), with shares up 12 percent. In trading on Friday, basic materials shares were relative laggards, down on the day by about 1.36 percent.

Top 5 Small Cap Stocks To Own Right Now: InterDigital Inc.(IDCC)

Interdigital, Inc. engages in the design and development of digital wireless technology solutions. The company offers technology solutions for use in digital cellular and wireless products and networks, including 2G, 3G, 4G, and IEEE 802-related products and networks. It holds patents related to the fundamental technologies that enable wireless communications. The company licenses its patents to equipment producers that manufacture, use, and sell digital cellular and IEEE 802-related products; and licenses or sells mobile broadband modem solutions, including modem IP, know-how, and reference platforms to mobile device manufacturers, semiconductor companies, and other equipment producers that manufacture, use, and sell digital cellular products. InterDigital?s solutions are incorporated in various products comprising mobile devices, such as cellular phones, tablets, notebook computers, and wireless personal digital assistants; wireless infrastructure equipment, such as base stations; and components, dongles, and modules for wireless devices. The company was founded in 1972 and is headquartered in King of Prussia, Pennsylvania.

Advisors' Opinion:
  • [By CRWE]

    InterDigital, Inc. (NASDAQ:IDCC) reported that certain of its subsidiaries have completed the previously announced sale of roughly 1,700 patents and patent applications to Intel Corporation for $375 million in cash.

Thursday, November 20, 2014

5 Best Oil Service Stocks To Watch For 2014

As 2013 comes to an end, oil prices and natural gas prices have surged due to demand and extremely cold weather across the nation. With exploration and production (E&P) companies hitting all-time usage levels in the major shale plays around the country, the top oil field services names may be poised to have an outstanding 2014.

In a new research report, the oil services analysts at Deutsche Bank are clearly very positive on the sector for next year. Although, the market has been negative to energy stocks as fears of weakening U.S. oil prices remain pervasive, the outlook for activity next year continues to improve. The Deutsche Bank team continues to think North American leverage will outperform next year, but fighting sentiment is a losing battle at the moment. So they are focused on stocks with events and catalysts for 2014.

Here are the seven top stocks in the sector to buy for 2014 from Deutsche Bank. The first four are the high conviction stocks to buy and have among the highest price targets on Wall Street.

Top Construction Material Stocks To Watch For 2015: MGT Capital Investments Inc (MGT)

MGT Capital Investments, Inc (MGT), incorporated in 1977, is a holding company. As of December 31, 2011, the Company was analyzing potential acquisition opportunities in healthcare marketing and technology, as well as various intellectual property assets. The Company has a controlling interest in Medicsight ltd (Medicsight) and its subsidiaries Medicsight, Inc., Medicsight KK (Japan), Medicsight Pty Limited (Australia), Medicsight FZE (UAE), MedicEndo Limited (UAE), MedicCO2lon Limited (UAE) and Medicsight UK Limited (UK). The Company also have wholly owned subsidiaries MGT Capital Investments (UK) Limited, MGT Investments (Gibraltar) Limited, and Medicsight. Medicsight and its wholly owned subsidiaries is a medical technology company focusing on medical imaging software development and medical hardware devices. On March 29, 2011 the Company disposed of its 49% holding in Moneygate Group Limited (Moneygate). In September 2013, MGT Capital Investments, Inc MGT Interactive, LLC acquired certain assets from Gioia Systems LLC.

Medicsight�� core technology is the ColonCAD algorithm that is integrated (using application protocol interface (API) technology) into visualization workstations for radiologists to use when reviewing a patient�� colon computer tomography (CT) scan data. The computer-aided detection (CAD) algorithm assists the radiologist as they search for polyps in the CT scan image data. The radiologist uses the visualization software to review the patient�� CT scan images on the screen and searches for polyps (potentially pre-cancerous lesions on the wall of the colon). After a full review, the radiologist then activates the Medicsight ColonCAD software, which immediately displays CAD marks on the images, drawing the radiologist�� attention to potential polyps and other regions of interest. The radiologist then assesses each marked region in order to make the final decision as to the presence or absence of a polyp.

In addition to the computer aided detection so! ftware applications, Medicsight has developed an automated carbon dioxide (CO2) insufflation device, MedicCO2LON. A patient undergoing a CT colon scan requires the colon to be insufflated (distended) with either CO2 gas or room air administered prior to the acquisition of their CT colonography images. MedicCO2LON is designed to provide insufflation, for the acquisition of images from the CT colonography examination.

The Company competes with GE, Hitachi, Philips, Siemens and Toshiba.

Advisors' Opinion:
  • [By Markman Advisors]

    Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market's attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).

5 Best Oil Service Stocks To Watch For 2014: Tencent Holdings Ltd (TCEHY.PK)

Tencent Holdings Limited is an investment holding company. The Company and its subsidiaries are principally engaged in the provision of Internet value-added services, mobile and telecommunications value-added services and online advertising services to users in the People�� Republic of China. The Company operates in four segments: Internet value-added services, Mobile and telecommunications value-added services, Online advertising, and Others. As of December 31, 2011, its subsidiaries included Tencent Cyber (Tianjin) Company Limited, Tencent Asset Management Limited, Tencent Technology (Beijing) Company Limited, Tencent Cyber (Shenzhen) Company Limited, Tencent Technology (Shanghai) Company Limited and others. Advisors' Opinion:
  • [By Eric Rodawig]

    In June 2012, Vivendi floated its then $8.1 billion stake in ATVI. However, the offering was not well received as there are very few companies that could afford to take over ATVI given its large market cap. Mentioned in the article, it is very likely that there are only three possible strategic buyers with the potential interest and capability to make such an acquisition: Microsoft, Disney, and Asian internet and gaming company Tencent (TCEHY.PK), which has a ~$60 billion market cap. Shortly after in August, Vivendi gave up on the sale.

  • [By Matthew Smith]

    Shares in Sohu.com (SOHU) continued their rapid rise, hitting yet another fresh 52-week high during the session, as the company announced the special dividend from Sohou yesterday (press release located here). Sohu.com will receive nearly $161.2 million in the transaction which is part of the overall $400 million deal with Tencent (TCEHY.PK) which was announced not too long ago. These are exciting times in the internet space as we move from computers to mobile devices, but China's internet landscape looks like the 'Wild West' right now and we expect to see further deals as companies jockey for position in their respective niches and consolidation begins as the larger players look to step up growth and gain exposure to new business segments.

5 Best Oil Service Stocks To Watch For 2014: UBIC Inc (UBIC)

UBIC, Inc. is a provider of e-discovery and digital forensic services for Asia and the world. The Company works with electronically stored information composed in Chinese, Japanese and Korean (CJK) languages and utilizes that expertise for clients involved in cross-border litigation, corporate investigations, intellectual property disputes and more. The Company's Lit i View platform is moving the industry from fact discovery to future discovery by allowing clients to analyze e-mail messages and digital communications found in big data to reveal patterns in human thought and behavior. Advisors' Opinion:
  • [By Lisa Levin]

    UBIC (NASDAQ: UBIC) shares fell 6.36% to touch a new 52-week low of $5.30. UBIC's trailing-twelve-month revenue is $58.74 million.

    Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

5 Best Oil Service Stocks To Watch For 2014: Condoto Platinum NL (CPD)

Condoto Platinum NL, formerly Bailey Minerals NL, is an Australia-based mineral explorer. The Company is focused on exploring gold deposits in its Mt Palmer and Mallee Hen Point projects. Mt Palmer project consists of 21 hectares of the Mt Palmer mine covered by mining lease M77/406, which has an area of 0.21 square kilometers. The project encompasses the Mt Palmer mine within the Southern Cross district of Western Australia. The project comprises the Palmer�� Find Gold Mine. The Mallee Hen Point is an undrilled five kilometers strike gold anomaly in the Yamarna Greenstone Belt. It is located on the Cosmo Newbury Aboriginal Reserve in the Great Victoria Desert and consists of one granted exploration licence with an area of 70 square kilometers. In April 2010, the Company entered into farmin and joint venture agreements with Drake Resources Limited to explore for gold on the Mt Palmer and Mallee Hen Point projects. Advisors' Opinion:
  • [By John Heinzl]

    Since April 1, the iShares S&P/TSX Canadian Preferred Share Index Fund (CPD) has dropped about 6.6%, excluding dividends. The fund is now yielding about 4.5%, up from 4.2% on April 1.

Friday, November 14, 2014

Top 10 Beverage Stocks To Buy For 2014

On Tuesday, small cap casual dining stock Red Robin Gourmet Burgers, Inc (NASDAQ: RRGB) was bucking the Dow to head higher after earnings, meaning its worth looking more closely at the stock to see what its doing right in the fickle restaurant space�plus take a look at the�performance of potential (non-fast food) peers like Frisch's Restaurants, Inc (NYSEMKT: FRS) and Sonic Corporation (NASDAQ: SONC).

What is Red Robin Gourmet Burgers, Inc?

Founded in 1969, small cap Red Robin Gourmet Burgers is�a casual dining restaurant chain calls itself the Gourmet Burger Authority for serving more than two dozen ��raveable, high-quality burgers with Bottomless Steak Fries.���n addition to its burger offerings, Red Robin Gourmet Burgers serves a wide variety of salads, soups, appetizers, entrees, desserts and signature Mad Mixology Beverages plus an extensive selection of local and regional beers and innovative adult beer shakes and cocktails. As of the end of the first quarter of 2014, there were 362 Company-owned Red Robin restaurants, five Red Robin's Burger Works and 129 franchised Red Robin restaurants ��a total of 496 restaurants across the United States and Canada.

Top Electric Utility Companies To Buy For 2015: MOJO Organics Inc (MOJO)

MOJO Organics, Inc., incorporated on August 2, 2007, engages in product development, production, marketing and distribution of CHIQUITA TROPICALS. CHIQUITA TROPICALS are a 100% fruit juice, produced under license agreement from Chiquita Brands. The Company�� product flavors include Banana Strawberry, Mango, Passion Fruit, and Pineapple.

The Company�� juices are produced without preservatives and without added sugar. The Company produces and packages the CHIQUITA TROPICALS products through production facilities and services on a contract basis.

The Company competes with The Coca-Cola Company and PepsiCo, Inc.

Advisors' Opinion:
  • [By Lisa Levin]

    Catalog & Mail Order Houses: The industry gained 1.13% by 10:15 am. The top performer in this industry was Mojo Organics (OTC: MOJO), which gained 6.6%. Mojo Organics shares have jumped 361.54% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.

Top 10 Beverage Stocks To Buy For 2014: Craft Brew Alliance Inc (BREW)

Craft Brew Alliance, Inc., incorporated on May 4, 1981, is an independent craft brewer. The Company is engaged in brewing, marketing and selling of craft beers in the United States. The Company operates two segments: Beer related operations and Pubs and Other. Beer related operations include the brewing and sale of craft beers from its five breweries. Pubs and Other operations primarily include its five pubs, four, of which are located adjacent to its breweries. The Company brews its Widmer Brothers, Redhook and Kona beers in each of its three mainland production breweries, including New Hampshire Brewery, Oregon Brewery and Washington Brewery. The Company also owns and operates a small manual style brewery, primarily used for small batch production at the Rose Quarter in Portland, Oregon. The Company�� beer portfolio is consisted of the Widmer Brothers, Redhook and Kona brand families. On May 2, 2011, the Company sold 42% interest in Fulton Street Brewery, LLC.

The Company�� Widmer Brothers Hefeweizen is a golden, cloudy wheat beer with a pronounced citrus aroma and flavor. This beer is usually served with a lemon slice. Its Drifter Pale Ale is brewed with generous amounts of summit hops. It also includes Drop Top Amber Ale and Rotator India Pale Ale. Initial beers in the series 924 series include the Nelson Imperial IPA and the Pitch Black IPA, which is a Pacific Northwest twist on a traditional IPA, brewed in the style of a Cascadian Dark. Beers in this brand are offered as a draft product and as a four pack for bottles. Widmer Brothers beers include Brothers��Reserve and Alchemy Project. Widmer Brothers seasonal beers are Citra Blonde, Okto, Brrr and W series.

The Redhook family of beers is consisted of sessionable (lower alcohol by volume) and approachable beers. Its Long Hammer IPA is the beer within the brand family and is English pub-style bitter ale with a bold hop aroma and profile that is not overpoweringly bitter. Its

Redhook Pilsner is a crisp, easy-! drinking, golden lager that is modeled after beers originally brewed in Plzen, Czechoslovakia. Redhook ESB is rich, full-bodied amber ale with a smooth flavor profile featuring toasted malts and a pleasant finishing sweetness. Its Copperhook Ale is copper-colored ale with caramel notes and a clean refreshing finish. The Company�� Blueline Series brand is offering from the Redhook brand family for the West Coast beer drinker. These beers are hand crafted by the brewers and are available at its Washington Brewery pub, as well as at select restaurants, bottle shops and public houses in the Seattle, Washington area. Its Brewery Backyard Series is produced at its New Hampshire brewery as a draft product available at the brewery�� pub and at select local establishments. Redhook seasonal beers include Nut Brown Ale, Winterhook Winter Ale and Wit.

The Company�� Kona Beers brand family is consisted of beers that deliver the essence of the Hawaiian Islands that is Always Aloha. The Company�� Longboard Island Lager is a traditionally brewed lager with a delicate, slightly spicy hop aroma that is complimented by a fresh, malt-forward flavor and a smooth, refreshing finish. Its Fire Rock Pale Ale is a crisp, Hawaiian Style pale ale with pronounced citrus and floral hop aromas and flavors that are backed up by a generous malt profile.

Kona seasonal beers include Koko Brown Ale, American brown ale with a deep amber color and rich mahogany hues. This ale has a smoky, roasted nut aroma and flavor, with a coconut twist. Koko Brown Ale is Kona�� spring seasonal. Its Pipeline Porter is smooth and dark, with a roasty aroma and earthy flavor. This ale is brewed with fresh 100% Kona coffee. Its Wailua Wheat is golden, sun-colored ale with a bright, citrusy flavor. This beer is brewed with a touch of tropical passion fruit to impart a slightly tart and crisp finish. Kona offers two variety packs: Island Hopper variety 12-packs and Big Kahuna variety 24-packs. Both packages include the brewe! ry�� Lo! ngboard Island Lager along with Fire Rock Pale Ale and then two of its Aloha series seasonal offerings: Koko Brown, Wailua Wheat and Pipeline Porter.

The Company competes with Heineken, Corona Extra and Guinness.

Advisors' Opinion:
  • [By Chris Katje]

    Publicly traded Craft Brew Alliance (BREW) is the owner of three key craft beer brands. The company, through two mergers, owns the brands Redhook, Widmer, and Kona. One of those brands (Redhook) has a partnership coming with Buffalo Wild Wings that could create coverage of the company's stock and blow revenue estimates out of the water.

  • [By Louis Navellier]

    The fantastic performance and growth of this company was noted by Portfolio Grader back in August and the stock was upgraded to an A. Shares of SAM stock remain a “strong buy” at the current price. When it comes to beer stocks to buy now, this is one of the most tempting.

    Best Booze Stocks to Buy Now -�Craft Brew Alliance (BREW)

    Craft Brew Alliance (BREW) makes craft beers under three very popular brands for beer aficionados. The Widmar Brothers, Redhook and Kona brands of beer have all received rave reviews … and that’s just one reason BREW is one of the best beer stocks to buy now.

Top 10 Beverage Stocks To Buy For 2014: Molson Coors Brewing Company(TAP)

Molson Coors Brewing Company brews, markets, sells, and distributes beer brands. It sells its products in Canada, under the Coors Light, Molson, Rickard's Red, Carling, Pilsner, Keystone Light, Creemore Springs, and Granville Island brands. The company also brews or distributes products under license from third parties, which include Heineken, Amstel Light, Murphy's, Asahi, Asahi Select, Miller Lite, Miller Genuine Draft, Miller Chill, Milwaukee's Best, Milwaukee's Best Dry, and Foster's. In addition, it imports, distributes, and markets the Corona, Coronita, Negra Modelo, and Pacifico brands, through a joint venture agreement with Grupo Modelo. Further, the company sells various brands in the United States, which include Coors Light, Miller Lite, Coors Banquet, Miller Genuine Draft, MGD 64, Miller Chill, Sparks, Miller High Life, Miller High Life Light, Keystone Light, Icehouse, Mickey's, Milwaukee's Best, Milwaukee's Best Light, Old English 800, Blue Moon, Henry Weinhard 's, George Killian's Irish Red, Leinenkugel's, Peroni Nastro Azzurro, Pilsner Urquell, Grolsch, Coors Non-Alcoholic, and Sharp's. Additionally, it sells various brands in the United Kingdom comprising Carling, C2, Coors Light, Worthington's, White Shield, Caffrey's, Kasteel Cru, and Blue Moon, as well as various regional ale brands. The company also sells the Grolsch brands through a joint venture with Royal Grolsch N.V. and the Cobra brands through a joint venture called Cobra Beer Partnership Ltd.; and distributes brands sold under license, including Corona, Coronita, Negra Modelo, Pacfico, Singha, and Magners Draught Cider. In addition, it markets and sells Zima, Si'hai, Coors Gold, and Coors Extra brands to various international markets. The company was formerly known as Adolph Coors Company and changed its name to Molson Coors Brewing Company as a result of its merger with Molson Inc. in February 2005. Molson Coors Brewing Company was founded in 1873 and is headquartere d in Denver, Colorado.

Advisors' Opinion:
  • [By BusinessWeek]

    Bud Light may still be America's best-selling beer -- it has been for more than a decade -- but retail sales of this and other leading lower-calorie lagers such as Bud Light Lime, Miller Lite, and Natural (aka Natty) Light, declined in 2013, according to data from IRI, a Chicago market research firm. Not that this spells the end of light beers, which still make up a significant chunk of the market. Even as big brewers push into the craft segment, some big-name labels are still experiencing an uptick. Case sales of Coors Light, which became the No. 2 beer brand in the U.S. in 2012, grew nearly 1.8 percent last year, according to IRI. Michelob Ultra Light sales were also up, although it is an outlier in a fast-declining Michelob franchise. "There will always be a place for 'Big Lager' as it's more drinkable in the sense that one can have many lagers but only a few dark beers," says Euromonitor International analyst Edward Hsyeh. "The dark beers are heavy in body, so there can only be so much 'share of the stomach' they possess." Still, big challenges loom: First, Americans' growing thirst for darker, more flavorful brews can't be ignored. Volume sales of lager-a lighter style of beer-have fallen every year since 2009 except 2012, according to Euromonitor's data, though the vast majority of beer consumed in the U.S. is still lager. Sales of pale ales, on the other hand, were up by 13 percent in 2013 alone, and wheat beer grew by 6 percent. The shift is reflected in the recent craft beer boom (volume sales grew 13 percent in the first half of 2013) in which India Pale Ale has become popular. Second, aside from craft, the big brands are seeing competition from imports, too. Modelo Especial volume sales, for example, more than doubled since 2009, according to IRI, and sales of Corona were up 11 percent. Last, hard ciders and new beer-like varieties such as AB InBev's (BUD) Bud Light Lime Straw-Ber-Rita, which sold more than 7 million cases since launching last

  • [By Lee Jackson]

    Molson Coors Brewing Co. (NYSE: TAP), like many beer companies, has seen beer consumption drop in favor of wine and liquor. The only standout in the recent poor numbers was an increase in sales of “above-premium beers.” Despite a new brewer opening up almost every day in the United States, Molson Coors accounts for nearly one of every three additional brews sold at the craft-brew level. Shareholders are paid a 2.7% dividend. Merrill Lynch lifts the price target from $50 to $52. The consensus target is $58.25. The stock closed Friday at $55.02.

  • [By Marc Bastow]

    Indeed, the diversity in the types of dividend stocks getting more generous made for an interesting week, from network provider Cisco (CSCO) to beer giant Molson Coors (TAP) to package delivery service UPS (UPS).

  • [By Lauren Pollock]

    Molson Coors Brewing Co.'s(TAP) third-quarter earnings fell 39% as the beer company’s results were hurt by a write-down tied to two European brands and revenue weakened slightly. Results were mixed as the bottom line beat views and the top line missed. Shares edged up 1.8% to $55 in light premarket trading.

Top 10 Beverage Stocks To Buy For 2014: PureSafe Water Systems Inc (PSWS)

PureSafe Water Systems, Inc., incorporated on March 9, 1987, is engaged in the design and development of its technology to be used in the manufacture and sale of water purification systems both in and outside the United States. The Company�� PureSafe First Response Water System (PureSafe FRWS) is self-contained and purifies most types of contaminated fresh or service water, including seawater that may be found at a first response emergency site. This system is mobile, by helicopter or transported by truck.

The PureSafe FRWS utilizes its technology which consists of water extraction boom that extracts water from the ocean, streams, ponds, pools of floodwater or a failed municipal distribution system. The extracted water is then treated by the application of advanced water treatment technologies which employ multiple stage filtration, multiple stage sanitation (including ozone, chlorine and ultraviolet purification techniques), reverse osmosis membranes, mineralization and final polishing to meet the standard drinking water requirements of the United States Environmental Protection Agency (the EPA). Its 2nd prototype (FRWS unit) unit can produce EPA compliant drinking from contaminated fresh or surface water at the rate of 30,000 gallons per day, to provide drinking water to 45,000 people. The unit has a built in generator and water bagging capability at the rate of 30,000 and a half liters bags of water per day

The Company competes with GE, Siemens, Severn Trent, Ecospheres Technology, Lenntech, Testa/Viwa, Lifekeeper, Mobile MaxPure, Bi Pure Water, Rodi, Global Water Group, Nirosoft, LifeStream, and Aquapura Tempest.

Advisors' Opinion:
  • [By John Udovich]

    Small cap Sodastream International Ltd (NASDAQ: SODA), an Israeli based developer, manufacturer and marketer of�home beverage carbonation systems, has attracted its share of hype over both its products and its stock, but could other small cap water stocks like Primo Water Corporation (NASDAQ: PRMW), Puresafe Water Systems Inc (OTCMKTS: PSWS) and Alkaline Water Company Inc (OTCBB: WTER) attract a similar following? After all, Sodastream International has managed to create a significant amount of buzz from consumers, investors and even short sellers because it�� the�world's largest manufacturer, distributor and marketer of home carbonation systems as its�brands are sold in over 60,000 retail stores in 45 countries. Sodastream International is also up 45.7% since the start of the year, up 70.2% over the past year and up 99.3% since November 2010, but shares did spike up to the $75 level in the middle of 2011 and now trade at the $63 level.

Top 10 Beverage Stocks To Buy For 2014: CirTran Corp (CIRC)

CirTran Corporation, incorporated on March 23, 1987, manufactures, markets, and distributes internationally an energy drink under a license with Playboy Enterprises, Inc. (Playboy) through its subsidiary, CirTran Beverage Corporation. It operates in Beverage Distribution and Contract Manufacturing segments. In the United States, it provides a mix of high- and medium-volume turnkey manufacturing services and products using various high-tech applications for electronics original equipment manufacturers (OEMs) in the communications, networking, peripherals, gaming, law enforcement, consumer products, telecommunications, automotive, medical, and semiconductor industries. The Company�� services include pre-manufacturing, manufacturing, and post-manufacturing services.

Beverage Distribution

CirTran Beverage Corporation (CirTran Beverage) manufactures, markets, and distributes Playboy-licensed energy drinks, flavored water beverages, and related merchandise through various distribution channels. As of December 31, 2012, the Company had 65 countries throughout Europe, Africa, Australia, the Pacific, and the Middle East.

Contract Marketing

CirTran Products Corp. pursues contract-manufacturing relationships in the domestic consumer products markets, including products in areas, such as home/garden, kitchen, health/beauty, toys, licensed merchandise, and apparel for film, television, sports, and other entertainment properties. The Company concentrates its product development efforts into three areas: home and kitchen appliances, beauty products, and licensed merchandise. Through CirTran - Asia, Inc., the Company designs, manufactures, and supplies products in the international electronics, consumer products, and general merchandise industries for various marketers, distributors, and retailers selling overseas. This subsidiary provides manufacturing services to the direct-response and retail consumer markets.

The Company competes with Hansen�! � Energy, Diet Red, Monster Energy, Lost Energy, Joker Mad Energy, Ace Energy, Unbound Energy, Rumba energy juice, Red Bull, Rockstar, Full Throttle, No Fear, Amp, Adrenaline Rush, 180, Extreme Energy Shot, Red Devil, Rip It, NOS, Boo Koo, and Vitaminenergy.

Advisors' Opinion:
  • [By CRWE]

    Last Friday, CIRC remained (0.00%) +0.000 at $.0005 at the close (ref. google finance August 30, 2013 ��Close).

    CirTran Corporation has recently filed its Quarterly Report on Form 10-Q for the period ended June 30, 2013, showing continued growth in sales and a dramatic improvement in profits. CirTran�� sales were again driven by its Playboy Energy Drink line, which has grown to represent nearly 98% of revenues.

    For the quarter, CirTran previously reported sales of $1,096,691, a 247% increase over the $315,755 reported for the same period a year ago. For the six months ended June 30, 2013, CirTran reported sales of 1,964,843, a 110% improvement over the $934,455 reported for the first half of 2012.

Top 10 Beverage Stocks To Buy For 2014: Fomento Economico Mexicano SAB de CV (FMX)

Fomento Economico Mexicano, S.A.B. de C.V. (FEMSA), incorporated on May 30, 1936, is a holding company. The Company conducts its operations through principal holding companies, each of which it refers to as a principal sub-holding company. These companies are Coca-Cola FEMSA, S.A.B. de C.V. (Coca-Cola FEMSA), which engages in the production, distribution and marketing of soft drinks, and FEMSA Comercio, S.A. de C.V. (FEMSA Comercio), which operates convenience stores. The Company�� convenience store chain OXXO operated a total of 7,492 stores as of March 31, 2010. Compania Internacional de Bebidas, S.A. de C.V. (CIBSA) owns a 53.7% interest in Coca-Cola FEMSA. On April 30, 2010, FEMSA announced the closing of the transaction, pursuant to which FEMSA agreed to exchange 100% of its beer operations conducted by FEMSA Cerveza for a 20% economic interest in the Heineken Group. In February 2009, Coca-Cola FEMSA acquired with The Coca-Cola Company the Brisa bottled water business in Colombia from Bavaria, a subsidiary of SABMiller. Coca-Cola FEMSA acquired the production assets and the rights to distribute in the territory, and The Coca-Cola Company obtained the Brisa brand.

Coca-Cola FEMSA, S.A.B. de C.V.

Coca-Cola FEMSA is a bottler of Coca-Cola trademark beverages. Coca-Cola FEMSA operates in various territories, including Mexico, a substantial portion of central Mexico (including Mexico City and the states of Michoacan and Guanajuato) and southeast Mexico (including the Gulf region); Central America, including Guatemala (Guatemala City and surrounding areas), Nicaragua (nationwide), Costa Rica (nationwide) and Panama (nationwide); Colombia; Venezuela; Argentina, including Buenos Aires and surrounding areas, and Brazil, including the area of greater Sao Paulo, Campinas, Santos, the state of Mato Grosso do Sul, the state of Minas Gerais and part of the state of Goias.

Coca-Cola FEMSA produces, markets and distributes Coca-Cola trademark beverages, own brands and b! rands licensed from the Company. The Coca-Cola trademark beverages include sparkling beverages (colas and flavored sparkling beverages), water, and still beverages (including juice drinks, ready-to-drink teas and isotonics). Out of the more than 100 brands and line extensions of beverages sold and distributed by Coca-Cola FEMSA, its most important brand, Coca-Cola, together with its line extensions, Coca-Cola light, Coca-Cola Zero and Coca-Cola light caffeine free, accounted for 61.4% of total sales volume during the year ended December 31, 2009. Coca-Cola FEMSA�� next largest brands, Ciel (a water brand from Mexico), Fanta (and its line extensions), Sprite (and its line extensions), ValleFrut and Hit, accounted for 10.5%, 5.8%, 2.6%, 1.5% and 1.3%, respectively, of total sales volume in 2009. Coca-Cola FEMSA uses the term line extensions to refer to the different flavors in which it offers its brands.

Coca-Cola FEMSA produces, markets and distributes Coca-Cola trademark beverages in each of its territories in containers authorized by The Coca-Cola Company, which consist of a variety of returnable and non-returnable presentations in the form of glass bottles, cans and plastic bottles made of polyethylene terephtalate (PET). Coca-Cola FEMSA uses the term presentation to refer to the packaging unit in which it sells its products. Presentation sizes for its Coca-Cola trademark beverages range from a 6.5-ounce personal size to a 3-liter multiple serving size. For all of its products excluding water, Coca-Cola FEMSA considers a multiple serving size as equal toor larger than one liter. In addition, it sells some Coca-Cola trademark beverage syrups in containers designed for soda fountain use, which it refers to as fountain. It also sells bottled water products in bulk sizes, which refers to presentations equal to or larger than five liters, which have a much lower average price per unit case than its other beverage products.

In Mexico, Coca-Cola FEMSA�� product portfolio consis! ts of Coc! a-Cola trademark beverages, and includes Mundet trademark beverages licensed from FEMSA in some Mexican territories. Coca-Cola FEMSA�� product sales in Latincentro consist predominantly of Coca-Cola trademark beverages. Per capita consumption of its sparkling beverages products in Colombia and Central America was 92 and 146 eight-ounce servings, respectively, in 2009. Its product portfolio in Venezuela consists of Coca-Cola trademark beverages. Sparkling beverages per capita consumption of its products in Venezuela was 174 eight-ounce servings during 2009. Coca-Cola FEMSA�� product portfolio in Mercosur consists mainly of Coca-Cola trademark beverages, and the Kaiser beer brand in Brazil, which Coca-Cola FEMSA sells and distributes on behalf of FEMSA Cerveza. Sparkling beverages per capita consumption of its products in Brazil and Argentina was 214 and 359 eight-ounce servings, respectively, in 2009.

The Company competes with Pepsi Beverage Company, Grupo Embotelladores Unidos, S.A.B. de C.V., Grupo Jumex, Groupe Danone, Cadbury Schweppes, Big Cola, Consorcio AGA, S.A. de C.V., Postobon, Florida Ice and Farm Co. S.A., Cerveceria Nacional, S.A., Pepsi-Cola Venezuela, C.A., AmBev and Quilmes Industrial S.A.

FEMSA Comercio, S.A. de C.V.

FEMSA Comercio operates a chain of convenience stores in Mexico, under the trade name OXXO. OXXO stores are concentrated in the northern part of Mexico, but also have a presence in central Mexico and the Gulf coast. FEMSA Comercio is the largest single customer of FEMSA Cerveza and of the Coca-Cola system in Mexico. During 2009, a typical OXXO store carried 1,954 different store keeping units (SKUs) in 31 main product categories.

The Company competes with 7-Eleven, Super Extra, Super City, Circle-K and AM/PM.

Advisors' Opinion:
  • [By Jonas Elmerraji]

    Fomento Economico Mexicano (FMX), better known as FEMSA, isn't another ascending triangle trade this week, unfortunately for shareholders. Instead, FEMSA is currently forming the bearish opposite of the pattern in Wells Fargo and Citi: a descending triangle.

    The descending triangle is formed by downtrending resistance above shares and a horizontal support level to the downside. In this case, that price floor comes in just below $90. The lower highs that form resistance in FMX signal that buying pressure is waning above the $100 level as long-suffering sellers opt to take gains near the high-end of this stock's recent range. Once that glut of demand at $90 gets taken out, a lot more downside looks likely for FMX.

    But now, MTB is forming a rounding bottom, a bullish setup that indicates a gradual shift in control of shares from sellers to buyers. The rounding bottom pattern looks exactly like it sounds, and even though MTB's pattern is actually at the top of its recent range, the trading implications are exactly the same. A breakout above $118 is the signal that the pattern is completed and it's time to be a buyer.

    With high short interest in MTB right now, a short squeeze could add some fuel to the fire on a breakout. Support looks reasonably strong at $110 -- that's the spot to keep your stop.

  • [By Monica Wolfe]

    Fomento Economico Mexicano SAB de CV (FMX)

    As of the close of the third quarter there were ten guru owners of Fomento Economico Mexicano. These gurus held a combined weighting of 1.99%. During the third quarter, there were four gurus making buys and seven making sells of their stake in FMX.

  • [By Dividends4Life]

    Memberships and Peers: PEP is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: The Coca-Cola Company (KO) with a 2.8% yield, Dr Pepper Snapple Group, Inc. (DPS) with a 3.2% yield and Fomento Econ (FMX) with a 1.7% yield.

  • [By Robert Martin]

    South Africa, China, Mexico and Brazil collectively make up 68% of ECON�� holdings. The top three holdings are Naspers LTD (NPSNY) at 10%, AmBev (ABV) at 8% and FEMSA (FMX) at 5.6%.

Top 10 Beverage Stocks To Buy For 2014: Brown-Forman Corp (BF.B)

Brown-Forman Corporation, incorporated on October 19, 1933, primarily manufactures, bottles, imports, exports, markets, and sells a variety of alcoholic beverage brands. The Company�� principal brands are Jack Daniel�� Tennessee Whiskey, Jack Daniel�� Tennessee Whiskey, Pepe Lopez Tequilas, Jack Daniel�� Single Barrel, Woodford Reserve Bourbons, Jack Daniel�� Ready-to-Drinks, Canadian Mist Blended Canadian Whiskies, Jack Daniel�� Tennessee Honey, Chambord Liqueur, Jack Daniel�� Winter Jack Chambord Vodka, Gentleman Jack, Collingwood Canadian Whisky, Southern Comfort, Early Times Bourbon, Southern Comfort Ready-to-Drinks, Early Times flavored line extensions, Southern Comfort flavored line extensions, Early Times Kentucky Whisky, Finlandia Vodkas, Korbel California Champagnes, Finlandia Ready-to-Drinks, Little Black Dress Vodkas, Antiguo Tequila, Maximus Vodkas, el Jimador Tequilas, Old Forester Bourbon, el Jimador New Mix Ready-to-Drinks, Sonoma-Cutrer Wines, Herradura Tequilas, and Tuaca Liqueur.

The Company�� products are sold in more than 150 countries around the world. The Company�� international markets include Australia, the United Kingdom, Mexico, Germany, Poland, France, Russia, Japan, Turkey, Canada, Spain, Czech Republic, South Africa, Brazil and Italy.

The Company competes with Bacardi Limited, Beam Inc., Davide Campari-Milano S.p.A., Diageo plc, LVMH Moet Hennessy Louis Vuitton S.A., Pernod Ricard S.A., and Remy Cointreau S.A.

Advisors' Opinion:
  • [By Sue Chang and Saumya Vaishampayan]

    BFB: Brown-Forman Corp. (BF.B) �Class B shares gained 3.7%. The alcoholic beverage maker reported fiscal third-quarter earnings Wednesday that beat expectations and boosted its full-year view on per-share earnings to between $2.95 and $3.05.

  • [By Holly LaFon]

    TR: Definitely. The most likely places that they��l probably pop up are counterparts to the same businesses that we already own because the economics are good for Richemont (XSWX:CFR). They sell precious jewelry and luxury goods and watches to aspirational consumers around the world. The same economics drive Swatch. I don�� own Swatch, in big measure. I own it for a handful of clients. But that�� kind of the natural sourcing ground for me. I don�� own Compari. I do own Pernod Ricard (PDRDF), Diageo (DEO), Brown Forman (BF.B). Compari�� a great company. They have different brands and strengths in different categories than the three companies that we already own. I could own Compari.

  • [By John Udovich]

    Whiskey has become increasingly cool and popular thanks to the whole cocktail movement, something that�� good for big whiskey stocks like Suntory Beverage & Food Limited (OTCMKTS: STBFY), Diageo plc (NYSE: DEO) and Brown-Forman Corporation (NYSE: BF.B) who�also produce a wide variety of�liquors and beverages. In fact,�a recent episode of the�Daily Ticker�cited these stats from a USA Today article:

Thursday, November 13, 2014

10 Best Forestry Stocks To Invest In Right Now

Fastenal Company�� (FAST) adjusted earnings of 41 cents per share in the second quarter of 2013 were in line with the Zacks Consensus Estimate. The earnings rose 7.9% year over year, on the back of year over year growth in revenue and margin.

Fastenal�� net sales of $847.6 million, lagged the Zacks Consensus Estimate of $857 million by 1.1%. Net sales grew 5.3% year over year, due to an increase in unit sales and favorable impact of the FAST solution initiative, which offset the decline in fastener sales.

Fastenal serves customers in the manufacturing and non-residential construction markets. Sales were slow in both the markets.

Quarter Details

Fastenal�� daily sales growth rates came in at 4.8%, 5.3% and 6.0% for the months of April, May and June, respectively, significantly down from the daily growth rates of 17.3%, 13.1% and 14.0% in the corresponding prior-year months. The sequential change in daily sales for 6 months from January to June also fell short of historical averages. Foreign exchange dragged second quarter daily sales growth rates by 0.1%.

Top 10 Heal Care Companies To Watch For 2015: Knoll Inc (KNL)

Knoll, Inc., incorporated on December 15, 1995, is a designer and manufacturer of workplace furnishings, textiles and fine leathers. The Company operates in three segments: Office, Studio and Coverings. The Office segment includes systems, seating, storage, tables, desks and KnollExtra ergonomic accessories, as well as the international sales of the Company's North American Office products. The Studio segment includes the Company's KnollStudio division, the Company's European subsidiaries, which primarily sell KnollStudio products, and Richard Schultz Design. The KnollStudio portfolio includes a range of lounge seating, side, cafe and dining chairs, barstools, and conference, dining and occasional tables. Richard Schultz Design provides outdoor furniture. The Coverings segment includes KnollTextiles, Spinneybeck (including Filzfelt), and Edelman Leather. In February 2014, Knoll Inc completed the acquisition of Holly Hunt Enterprises, Inc.

Office Segment

The Company�� systems furniture consists principally of functionally integrated panels or table desks, work surfaces, pedestal and other storage units, power and data systems and lighting. The Company's systems furniture product lines include panel and desk-based planning models, which consists of Antenna Workspaces, Reff Profiles, AutoStrada, Dividends Horizon, Morrison, Equity and Currents. The Company�� principal seating product lines include generation by Knoll, ReGeneration by Knoll, LIFE, RPM and Chadwick. Essentials Work Chairs' Pro, Tech, and Sport models offer a range of four task and two side chairs suitable to any office style from the traditional to the progressive. The Company�� files and storage products, featuring the Template, Calibre and Series 2 product lines, are designed with features to maximize storage capabilities throughout the workplace.

The Company�� core files and storage products consist of lateral files, mobile pedestals and other storage units, bookcases and overhead storage ! cabinets.. The Company offers collections of adjustable tables, as well as meeting, conference, training, dining, and cafe tables for large scale projects and standalone desks and table desks. The Company's Interaction and Upstart product lines include adjustable, work, meeting, conference and training tables. These product lines range from independent tables to tables suitable for workstations that support individual preferences for computer and writing heights to plannable desks that can be linked together to build and reshape larger work areas. KnollExtra offers accessories that complement Knoll office furniture products, including technology support accessories, desktop organizational tools, lighting and storage.

Studio Segment

The KnollStudio portfolio includes a range of lounge seating; side, cafe and dining chairs, barstools, and conference, dining and occasional tables. The Company�� studio segment includes the Knoll Europe businesses. Knoll Europe provides products and services primarily to its European clients, whose aesthetics and styles can be different from its North America clients. A majority of Knoll Europe's business is Knoll Studio products, but Knoll Europe also offers a product profile that enables its customers to purchase a complete office environment. In addition, it offers certain products designed specifically for the European market. In Europe, the core product categories include KnollStudio, desk systems, including the Wa desking system, the KnollScope, and the PL1 system, seating, including a range of chairs, and storage units, which are designed to complement Knoll desk products. During 2012, it acquired Richard Schultz Design, Inc., a designer and manufacturer of outdoor furniture for the residential, hospitality, and contract office furniture markets.

Coverings Segment

The Company's Coverings segment consists of KnollTextiles, Spinneybeck Leather (including Filzfelt products), and Edelman Leather. KnollTextiles offers u! pholstery,! panel fabrics, wallcoverings and drapery that harmonize color, pattern and texture and offers products for corporate, hospitality, healthcare and residential interiors. KnollTextiles products are used in the manufacture of Knoll furniture and are sold to clients for use in other manufacturers' products. Spinneybeck Enterprises, Inc., (Spinneybeck), the Company's wholly owned subsidiary, offers leathers and related products, including leather rugs and wall panels. Spinneybeck supplies upholstery leather for use on Knoll furniture and for sale directly to clients, including other office furniture manufacturers, upholsterers, aviation, custom coach and boating manufacturers. Edelman Leather LLC, (Edelman) its wholly owned subsidiary, supplies fine leathers to residential, hospitality, aviation and contract office furniture markets. Edelman, offers a residential showroom network where designers and retail consumers can sample its products.

The Company competes with Herman Miller, Inc., Steelcase, Inc., Haworth, Inc., HNI Corporation and Teknion Corporation.

Advisors' Opinion:
  • [By John Udovich]

    Small cap office furniture stock Steelcase Inc (NYSE: SCS) jumped 11.66% after beating earnings expectations, meaning it might be time to take a closer look at the stock along with potential office or commercial furniture stock peers like�HNI Corp (NYSE: HNI), Knoll Inc (NYSE: KNL) and Virco Mfg. Corporation (NASDAQ: VIRC). After all, the performance of any company selling office or commercial furniture would tend to give some insights into the office or employment markets.

  • [By Ben Levisohn]

    Shares of HNI Corp. have gained 4.9% to $35.17 at 1:45 p.m., while Steelcase (SCS) has risen 0.8% to $16.93, Knoll (KNL) has advanced 2.5% to $18.74 and Herman Miller (MLHR) has ticked up 0.3% to $30.57.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Knoll (NYSE: KNL  ) , whose recent revenue and earnings are plotted below.

10 Best Forestry Stocks To Invest In Right Now: Carnival Plc ADS (CUK)

Carnival plc operates as a cruise company. It operates in North America Cruise Brands, EAA Cruise Brands, and Tour and Other segments. The company offers cruises under the brand names of Carnival Cruise Lines, Holland America Line, Princess Cruises, and Seabourn in North America; and AIDA Cruises, Costa Cruises, Cunard, Ibero Cruises, P&O Cruises (UK), and P&O Cruises (Australia) in Europe, Australia, and Asia. It also owns Holland America Princess Alaska Tours, a tour operator in Alaska and the Canadian Yukon, which owns and operates 12 hotels or lodges, 300 motor coaches, and 20 domed rail cars. The company sells its cruises through travel agents, including wholesalers, general sales agents, and tour operators. Carnival plc was founded in 1850 and is headquartered in London, the United Kingdom.

Advisors' Opinion:
  • [By Rich Duprey]

    Cruise ship operator�Carnival (NYSE: CCL  ) (NYSE: CUK  ) �announced today its third-quarter dividend of $0.25 per share, the same rate it's paid since 2011.

10 Best Forestry Stocks To Invest In Right Now: CEVA Inc.(CEVA)

CEVA, Inc., together with its subsidiaries, engages in licensing silicon intellectual property (SIP) for the handsets, mobile broadband, portable, and consumer electronics markets primarily in the United States, Europe, the Middle East, and the Asia Pacific. It designs and licenses DSP cores in the form of a hardware description language definition; a portfolio of application-specific platforms, including wireless baseband, audio, imaging and vision, voice over Internet protocols (VoIP), Bluetooth, and serial storage technology and serial attached SCSI; and development platforms, software development kits, and software debug tools that facilitate system design, debug, and software development. The company?s intellectual property (IP) is used by semiconductor and original equipment manufacturer companies for application-specific integrated circuits and application-specific standard products. It serves various markets, including feature phones, smartphones, machine to machi ne for various cellular standards, home entertainment, portable game consoles, and serial storage and telecommunication devices. CEVA, Inc. markets its technology through a direct sales force. The company was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. CEVA, Inc. was founded in 1999 and is headquartered in Mountain View, California.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CEVA (Nasdaq: CEVA  ) , whose recent revenue and earnings are plotted below.

10 Best Forestry Stocks To Invest In Right Now: Accretive Health Inc. (AH)

Accretive Health, Inc. provides revenue cycle management services for hospitals and healthcare providers in the United States. It offers integrated revenue cycle management services that help healthcare providers to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections; quality and total cost of care services, which enable healthcare providers to manage the health of a defined patient population by identifying those individuals who are most likely to experience an adverse health event; and physician advisory services. Accretive Health, Inc. serves multi-hospital systems, including faith-based or community healthcare systems, academic medical centers, independent ambulatory clinics, and physician practice groups. The company was formerly known as Healthcare Services, Inc. and changed its name to Accretive Health, Inc. in August 2009. Accretive Healt h, Inc. was founded in 2003 and is headquartered in Chicago, Illinois.

Advisors' Opinion:
  • [By Jon C. Ogg]

    Accretive Health Inc. (NYSE: AH) was downgraded to Neutral from Outperform at Credit Suisse.

    Beam Inc. (NYSE: BEAM) was downgraded to Hold from Buy based on valuation at Argus.

10 Best Forestry Stocks To Invest In Right Now: iShares Government/Credit Bond ETF (GBF)

iShares Lehman Government/Credit Bond Fund (the Fund) seeks investment results that correspond to the price and yield performance of the United States Government and investment-grade United States corporate securities of the United States bond market as defined by the Lehman Brothers U.S. Government/Credit Index (the Index). The Fund invests in a representative sample of the securities in the Index, which has a similar investment profile as the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

The Index measures the performance of United States dollar-denominated United States Treasuries, government-related securities and investment-grade United States corporate securities that have a remaining maturity of greater than or equal to one year, and have more than $250 million or more of outstanding face value. The securities must be fixed-rate and non-convertible securities.

Advisors' Opinion:
  • [By Jonathan Morgan]

    Bilfinger SE (GBF) climbed 3.1 percent to 74.30 euros. Germany�� second-largest builder predicted a significantly stronger second half after reporting second-quarter net income of 47 million euros ($62.5 million), which was in line with analysts�� estimates.

10 Best Forestry Stocks To Invest In Right Now: Navios Maritime Holdings Inc. (NM)

Navios Maritime Holdings Inc. operates as a seaborne shipping and logistics company. It focuses on the transportation and transshipment of dry bulk commodities, including iron ore, coal, fertilizers, and grains. The company controls a fleet of 31 owned vessels and 26 chartered-in vessels totaling 5.8 million dwt. Its owned fleet comprises 14 Ultra Handymax, 11 Capesize, 1 Handysize, and 3 Panamax vessels, as well as 2 Panamax vessels under construction; and chartered-in vessels consists of 8 Capesize, 11 Panamax, 1 Handysize, and 6 Ultra Handymax vessels under long-term time charters. The company also engages in port terminal, river barge, and coastal cabotage operations; and charters its vessels under medium to long-term charters to trading houses, producers, and government-owned entities. In addition, it engages in operating ports and transfer station terminals; and handles vessels, barges, and push boats, as well as operates upriver transport facilities in the Hidrovia region. Further, the company engages in the transportation and handling of liquid cargoes through the ownership, operation, and trading of tanker vessels. It has operations primarily in North America, Europe, Asia, and South America. The company is headquartered in Piraeus, Greece.

Advisors' Opinion:
  • [By Nickey Friedman]

    Navios Maritime Holdings (NYSE: NM  ) has two operating segments: shipping and logistics. Analysts have already begun to raise their profit estimates for 2014, currently at $0.11 EPS up from $0.01 a week ago. Expect that number to continue to rise dramatically. Navios pays a $0.06 per share quarterly dividend and trades around 40% below its book value. It used to trade as high as $17 back in 2007.

10 Best Forestry Stocks To Invest In Right Now: Sonora Gold and Silver Corp (SOC)

Sonora Gold & Silver Corp. (Sonora) is a Canadian-based mineral exploration company based in Vancouver, British Columbia, Canada focused on exploration and development of precious metal projects. The Company�� blocks include Los Pavitos, the Christina and the Brenda, all located in the state of Sonora, Mexico and each consisting of 10,000 hectares in size. Sonora is exploring for commercially exploitable mineral deposits and is focused on deposits located in Tanzania, Africa. The Negese property covering an area of approximately 10 square kilometres located in the Negese Area in Kilindi District, Tanzania. As of January 31, 2012, operational focus has been primarily on the exploration of gold and silver mineral properties with the objective of identifying commercially exploitable mineralization. Advisors' Opinion:
  • [By Triska Hamid]

    In Abu Dhabi, researchers at the ATIC-SRC Center of Excellence for Energy Efficient Electronic Systems (ACE4S), a center jointly established by the Advanced Technology Investment Company and the Semiconductor Research Corporation, are working on the development of systems on chip (SOC) and micro-electromechanical systems (MEMs) in health care.

Tuesday, November 11, 2014

Top Information Technology Companies For 2014

Salesforce.com (NYSE: CRM  ) first announced its intention to acquire cloud-based digital marketing leader ExactTarget for an estimated $2.5 billion on June 4, 2013. Just over a month later, the deal has been completed, Salesforce.com said today.

Salesforce.com intends to integrate ExactTarget solutions into its industry-leading CRM in an effort to "create a world-class marketing platform across email, social, mobile and the web," according to today's release.

In support of Salesforce.com's objective to expand its cloud-marketing solutions with the acquisition of ExactTarget, it cited Gartner�research that indicates, "CMOs will outspend CIOs on information technology by 2017."

In discussing the opportunity that ExactTarget solutions offer, Salesforce.com Chairman and CEO Marc Benioff cited data compiled by Gartner�that predicts, "CMOs will outspend CIOs on information technology by 2017." Benioff added, "The addition of ExactTarget makes Salesforce the starting place for every company and puts salesforce.com in the pole position to capture this opportunity."�

Hot Value Companies To Watch In Right Now: Arch Coal Inc. (ACI)

Arch Coal, Inc. produces and sells thermal and metallurgical coal from surface and underground mines located in the United States. As of December 31, 2013, it operated or contracted out the operation of 22 mines, and owned or controlled approximately 5.3 billion tons of proven and probable recoverable reserves. The company also owned or controlled primarily through long-term leases approximately 32,135 acres of coal land in Ohio; 22,417 acres of coal land in Maryland; 46,532 acres of coal land in Virginia; 425,038 acres of coal land in West Virginia; 107,668 acres of coal land in Wyoming; 267,024 acres of coal land in Illinois; 19,428 acres of coal land in Montana; 21,802 acres of coal land in New Mexico; and 20,166 acres of coal land in Colorado, as well as coal land in Kentucky. In addition, it owned or controlled through long-term leases smaller parcels of property in Alabama, Indiana, Washington, Arkansas, California, Utah, and Texas. The company sells coal to power pl ants, steel mills, and industrial facilities. Arch Coal, Inc. was founded in 1969 and is headquartered in St. Louis, Missouri.

Advisors' Opinion:
  • [By Ben Levisohn]

    The price of natural gas, however, has dropped 0.4% today, and wouldn’t you know it, coal stocks are weak. Cloud Peak Energy (CLD) has dropped 4.2% to $16.15, while Peabody Energy (BTU) has fallen 2.9% to $17.27. Arch Coal (ACI) is off 1.3% at $4.45, Alpha Natural Resources (ANR) has declined 1.4% to $5.76 and Consol Energy (CNX) has dipped 0.7% to $31.35.

  • [By Matt DiLallo]

    Norfolk
    The Norfolk area is home to coal-terminal operator Dominion Terminal Associates, among others. The facility is jointly owned by Peabody Energy (NYSE: BTU  ) , Arch Coal (NYSE: ACI  ) , and Alpha Natural Resources (NYSE: ANR  ) , which use it to ship coal around the world. It's a state-of-the-art facility that features many environmental safeguards to keep the 1.7 million net tons of coal storage capacity from causing any environmental damage. Overall, coal exports provide significant economic benefits to Norfolk as well as the state of Virginia as a whole. It's estimated that coal exports contributed to more than 19,000 jobs to the state and added $2.5 billion in related economic value.�

  • [By Ben Levisohn]

    Shares of Arch Coal (ACI) have plunged today after Morgan Stanley downgraded the company after predicting that even-cheaper natural gas would knock down coal prices–and Arch’s profits.

    Bloomberg News

    Morgan Stanley’s Stephen Byrd and team explain:

    NAPP coal demand is at the highest risk from negative gas basis in Marcellus and Utica. Although coal demand has rebounded from 2012, we see 2013 as a near term peak as regional gas prices in the production-heavy mid-Atlantic erodes NAPP demand. Although NAPP falls lower on a generic cost curve than CAPP, it is burned primarily in regions exposed to cheap gas from Marcellus and Utica production. We expect weak gas basis relative to Henry Hub to spread though PA, NJ, WV and even Ohio and Downstate NY in 2014, reducing capacity factors at coal plants in these regions. We see ~8mm tons decrease in PJM NAPP coal burn in 2014 relative to 2013.

    That’s bad for Arch Coal, Byrd says. He writes:

    We are downgrading Arch to Underweight from Equal-weight, driven by our more negative view of the domestic thermal coal market. Arch is a thermal-heavy name with significant balance sheet leverage, making the company vulnerable to prolonged depressed market conditions.

    Also taking a hit: Exelon (EXC), which Byrd downgraded to Underweight from Overweight.

    It’s not all bad news, however. Two utilities should benefit from this trend, Calpine (CPN) and Dominion Resources (D), although the advantage may already be priced into Dominion’s shares, Byrd says.

    Sahes of Arch Coal have dropped 5.3% to $3.90 at 3:03 p.m. today,�while Excelon has dropped 3.2% to $28.59. Calpine has gained 0.7% to $19.37 and Dominion is up 1.1% at $62.49. Consol Energy (CNX), which is also exposed to East Coast coal is down 2.1% at $37.55.

Top Information Technology Companies For 2014: Cereplast Inc (CERPQ)

Cereplast, Inc. (Cereplast), incorporated on September 29, 2001, is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. The Company primarily conducts its operations through product families, such as Cereplast Compostables resins, Cereplast Hybrid Resins and Cereplast Algae Plastic resins. In October 2011, the Company purchased a manufacturing plant in Assisi (Cannara).

Cereplast Compostables resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. The Company offers 13 commercial grades of Compostable resins in this product line. Cereplast Sustainables resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications. The Company offers six commercial grades of Sustainable resins in this product line. Cereplast Hybrid Resins products replace up to 55% of the petroleum content in conventional plastics with bio-based materials, such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins, such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. The first commercial product with Cereplast Algae Plastic resin is being produced and sold as part of the Company's Sustainables resin family.

The Company's Compostable resins are renewable substitutes for petroleum-based plastics targeting primarily single-use disposables. The Company's Compost! able Resins have been used to produce foodservice ware, including the first line of fully biodegradable and compostable foodservice ware. Cereplast Hybrid Resins uses renewable materials such as starches from corn and tapioca.

Cereplast competes with BASF, Dow Chemical, Lyondell Basell, DuPont, SABIC, Novamont, NatureWorks and Telles.

Advisors' Opinion:
  • [By Bryan Murphy]

    The whole thing may seem a little "out there" at first glance, but truth be told, what Metabolix, Inc. does isn't terribly unusual anymore. It's just a little less sexy than what traders and stock speculators usually want to see and hear with their picks. Kraton Performance Polymers Inc. (NYSE:KRA) and the now-bankrupt Cereplast Inc. (OTCMKTS:CERPQ) are/were in the same business, along with several others. [Don't let the Cereplast bankruptcy filing deter you - it wasn't a lack of opportunity that up-ended CERP.]

Top Information Technology Companies For 2014: Tonix Pharmaceuticals Holding Corp (TNXP)

Tonix Pharmaceuticals Holding Corp., incorporated on November 16, 2011, is a specialty pharmaceutical company focused on developing novel pharmaceutical products for disorders of the central nervous system (CNS). The Company develops TNX-102 sublingual tablet, or TNX-102 SL. TNX-102 SL is a novel dose and formulation of cyclobenzaprine (CBP), the active pharmaceutical ingredient of two prescribed muscle relaxant products, Flexeril and Amrix. TNX-102 SL is also intended for chronic use. It develops TNX-102 SL for the treatment of FM under a United States Investigational New Drug application (IND), and under three clinical trial applications (CTAs), filed in Canada. It also develops TNX-102 SL for the treatment of post-traumatic stress disorder (PTSD). As of January 25, 2013, the Company focuses on product development, and had not generated any revenues.

The Company searches for potential therapeutic solutions among known pharmaceutical agents that lack regulatory approval for the indications it seeks, but may be approved for use in other indications. It seeks to create new dose and formulation options that are tailored to the therapeutic uses to which it applies these agents. TNX-102 SL is a small, rapidly disintegrating tablet containing CBP for sublingual administration at bedtime. The Company designed TNX-102 SL for delivery of CBP to the systemic circulation through sublingual transmucosal absorption and to avoid first-pass liver metabolism.

CBP is the active pharmaceutical ingredient in its lead product candidate, TNX-102 SL. In addition to CBP, TNX-102 SL contains inactive ingredients, called excipients, which are approved for pharmaceutical use. In addition to TNX-102 SL, it develops other formulations of CBP, including TNX-102 promicellar gelatin capsule, or TNX-102 gelcap. It developed TNX-102 gelcap under an agreement with Lipocine, Inc. (Lipocine), a contract formulation developer and small-scale manufacturer. In addition it has other pipeline of other product cand! idates, including TNX-201 and TNX-301. TNX-201 is based on isometheptene mucate and is under development as a treatment for certain types of headaches.

Advisors' Opinion:
  • [By John Udovich]

    It�� a new year and the first one and a half trading weeks of 2014 has not disappointed biotech investors as the sector and mid cap or small cap biotech or�pharma stocks like Intercept Pharmaceuticals Inc (NASDAQ: ICPT), Epizyme Inc (NASDAQ: EPZM), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and TNI BioTech Inc (OTCQB: TNIB) either surging or producing some news plus there have been IPO filings for future listings for�Flexion Therapeutics (NASDAQ: FLXN), Aldexa Therapeutics (NASDAQ: ALDX), Retrophin (NASDAQ:�RTRX) and Dicerna Pharmaceuticals (NASDAQ: DRNA). Consider the following news so far this year:

Top Information Technology Companies For 2014: Lincoln Educational Services Corporation(LINC)

Lincoln Educational Services Corporation provides post-secondary education services in the United States. The company offers degree and diploma programs for recent high school graduates and working adults in the areas of studies, such as health science, automotive technology, skilled trades, business and information technology, and hospitality services. As of December 31, 2011, it had 19,204 enrolled students. The company operates 46 schools in 17 states under Lincoln Technical Institute, Lincoln College of Technology, Lincoln College of New England, Nashville Auto-Diesel College, and Euphoria Institute of Beauty Arts and Sciences brand names, as well as offers online programs. Lincoln Educational Services Corporation was founded in 1946 and is headquartered in West Orange, New Jersey.

Advisors' Opinion:
  • [By Jon C. Ogg]

    Teradyne will replace Scholastic Corp. (NASDAQ: SCHL) in the S&P MidCap 400, and Scholastic will replace Lincoln Education Services Corp. (NASDAQ: LINC) in the S&P SmallCap 600. Lincoln Education Services currently ranks 600th in the S&P SmallCap 600 and is no longer representative of the small cap market space.

Top Information Technology Companies For 2014: Federal Realty Investment Trust (FRT)

Federal Realty Investment Trust (the Trust) is an equity real estate investment trust (REIT) specializing in the ownership, management, and redevelopment of retail and mixed-use properties located in metropolitan markets in the Northeast and Mid-Atlantic regions of the United States, as well as in California. As of December 31, 2011, the Trust owned or had interest in community and neighborhood shopping centers and mixed-use properties, which are operated as 87 retail real estate projects, consisting approximately 19.3 million square feet. On December 30, 2011, it acquired an 8.1 acre land parcel adjacent to Plaza El Segundo. In January 2012, the Company acquired 89.9% interest in Montrose Crossing. In January 2013, the Company acquired East Bay Bridge shopping center. In April 2013, it acquired a shopping center on 9 acres directly across from the Noroton Heights train station. In January 2014, Federal Realty Investment Trust acquired controlling interest in two shopping centers totaling 285,600 square feet in affluent Monmouth County, New Jersey.

The Company�� portfolio includes retail in many formats ranging from regional community and neighborhood shopping centers, which are anchored by grocery stores to mixed-use properties, which are centered around a retail component but also include office, residential and/or hotel components. During the year ended December 31, 2011, the Company signed leases for a total of 1,417,000 square feet of retail space, including 1,294,000 square feet of comparable space leases. As of December 31, 2011, the real estate projects were 93.4% leased and 92.4% occupied. As of December 31, 2011, it owned a 30% interest in seven retail real estate projects totaling approximately one million square feet. As of December 31, 2011, the Company owned 90.9% interest in joint venture properties, which were leased and occupied.

Advisors' Opinion:
  • [By Ken McGaha] rong>These Businesses Aren�� Cheap By Any Measure

    Value investors, such as myself, seem to always be compulsive about business fundamentals when assessing fair value. The numbers here do not paint a pretty picture in terms of compelling value.

    Company Ticker

    KRC

    KIM

    EGP

    FRT

    Dividend Yield

    2.25%

    3.88%

    3.34%

    2.54%

    Payout Ratio

    1,031%

    171%

    199%

    147.91%

    5-Div. Gwth.

    -9.61%

    -12.64%

    0.54%

    3.69%

    2014 P/E Ratio

    22.79

    16.69

    18.85

    25

    5-yr. Proj. Gwth.

    7.2%

    4.3%

    6.3%

    6.5%

    Price/Cash Flow

    22.12

    15.77

    17.92

    24.88

    Being a value oriented investor, I am always looking for ways to mitigate my risk and increase my upside potential through the acquisition of valuable assets at distressed prices. That is not what I see here. Each of these businesses are trading at huge multiples to their projected earnings growth rates for the next 5 years.

    In terms of the prices to free cash flow, KIM and EGP trade at multiples that would be reasonable for world-class businesses that are dominant in a critical industry. But a commercial REIT? I don�� think so. The price to cash flow multiples for KRC and FRT are simply outrageous for these businesses and would be very difficult to justify for any business. Are you really willing to buy a business that will take between 22 and 25 years to earn enough money to pay you back? Not me.

    Excellent Management Can Justify High Valuations

    Quite often in my life, I have come across people who failed to understand the distinction between price and cost or price and value. A business that appears to be expensive on the surface can, and sometimes does, offer an excellent value due to the existence of exceptional manage

  • [By Brad Thomas]

    REITs mentioned: (VTR), (OHI), (O), (DLR), (HCP), (HTA), (KIM), (FRT), (SPG), and (SKT).

    Note: This article is intended to provide information to interested parties. As I have no knowledge of individual investor circumstances, goals, and/or portfolio concentration or diversification, readers are expected to complete their own due diligence before purchasing any stocks mentioned or recommended.

  • [By Dan Burrows]

    Heck, over the last 20 years, NNN stock generated an annual return of 12.3%. That beats the broader market by more than 3 percentage points, making this one of the top dividend stocks to ride out any roughness.

    Dependable Dividend Stocks: Federal Realty Investment Trust (FRT)

    Dividend Yield: 2.8%
    YTD Gain: 12%

  • [By Shauna O'Brien]

    Jefferies reported on Wednesday that it has upgraded real estate investment trust Federal Realty Investment Trust (FRT).

    The firm has raised its rating on FRT from “Hold” to “Buy,” and has increased the company’s price target from $112 to $116. This price target suggests a 13% upside from the stock’s current price of $100.75.

    Analyst Omotayo Okusanya noted: “Based on our recent tour of Assembly Row, we are now convinced about the long term value of this development project. Our recent management meetings on Sept 4th also indicate that: 1) development projects at Pike and Rose as well as Santana Row remain on track and 2) FRT remains on track to keep generating industry leading SS NOI growth. With FRT also well positioned for rising rates, we find the story compelling and upgrade the stock to Buy from Hold.”

    Looking ahead, the firm has cut its estimates for FY2013 from $4.64 to $4.62 per share. FY2014 estimates have also been lowered from $4.97 to $4.96 per share.

    Federal Realty Investment Trust shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

Top Information Technology Companies For 2014: Peoples Bancorp of North Carolina Inc.(PEBK)

Peoples Bancorp of North Carolina, Inc. operates as the holding company for Peoples Bank, which provides various banking products and services to individuals and small to medium-sized businesses in Catawba Valley and surrounding communities in North Carolina. Its deposit products include demand deposits; interest-bearing checking accounts; NOW, MMDA, and savings deposits; regular savings accounts; money market accounts; time deposits; and certificates of deposit. The company?s lending portfolio comprises commercial loans, real estate mortgage loans, real estate construction loans, and consumer loans, as well as agricultural loans. It also provides real estate appraisal and real estate brokerage services, as well as access to investment counseling and non-deposit investment products, such as stocks, bonds, mutual funds, tax deferred annuities, and related brokerage services. It operates 22 banking offices located in Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Cla remont, Hiddenite, Hickory, Charlotte, Monroe, Cornelius, Mooresville, and Raleigh in North Carolina, as well as a loan production office in Denver, North Carolina. The company was founded in 1912 and is based in Newton, North Carolina.

Advisors' Opinion:
  • [By Tim Melvin]

    Peoples Bank of North Carolina (PEBK) has also seen strong insider buying recently. One director as well as the CEO and Chairman of the board have made open market purchases of the stock in the past few months. The bank serves the central areas of North Carolina and also operates Banco de la Gente, which has four branches that serve the region�� fast-growing Latin American community. The bank serves a market with above-average economic prospects and has a very attractive 22-branch network that is likely to attract the attention of larger banks in the region.

  • [By Tim Melvin]

    Stilwell�� funds also bought more shares of Peoples Bancorp of North Carolina (PEBK). The bank operates in central North Carolina and has 22 branches with a little over $1 billion in assets. PEBK just reported a solid quarter, increasing earnings by more than 40% year-over-year while working down nonperforming assets by 30%. The bank also grew its deposit base in the quarter — a difficult accomplishment for many small banks this year.

Monday, November 10, 2014

Best Biotech Companies To Invest In Right Now

Netflix (NASDAQ: NFLX  ) has been a poster boy for market success in 2013. The stock has gained 134% in value during the first six months of the year and is one of the strongest performers outside of ultra-risky penny stocks. The digital video maven earned it by collecting more than 30 million domestic customers and more than 7 million viewers abroad, while also producing high-quality original shows and locking up even more third-party content deals.

As successful as Netflix stock has been this year, it's not the biggest winner of all. In fact, it's just the 15th strongest performer among reasonably sized Russell 3000 members. Let's take a closer look at four of the stocks that managed to outperform Netflix so far, using the video veteran as the benchmark to beat.

CLVS Total Return Price data by YCharts.

No. 1 with a bullet
Nobody, but nobody, is beating Clovis Oncology (NASDAQ: CLVS  ) right now. The cancer-focused biotech company got the party started with a fine earnings report in February, which helped push the stock 15% higher overnight. But that's nothing next to the 136% one-day pop Clovis experienced after releasing positive data from early-stage studies on two types of cancer-busting drugs.

Top International Stocks To Buy Right Now: Taro Pharmaceutical Industries Ltd (TARO)

Taro Pharmaceutical Industries Ltd., incorporated in 1959, is a science-based pharmaceutical company. The Company develops manufactures, and markets prescription and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada and Israel. The Company also develops and manufactures active pharmaceutical ingredients (APIs), primarily for use in its finished dosage form products. The Company�� primary areas of focus include pediatric creams and ointments, liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company operates through three companies: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries (including indirect), Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets more than 180 pharmaceutical products in over 25 countries.

Taro Israel manufactures more than 160 finished dosage form pharmaceutical products for sale in Israel and for export. It produces APIs used in the manufacture of finished dosage form pharmaceutical products. It markets and distributes generic products in the local Israeli market. Taro Israel�� primary product lines include dermatology, prescription and OTC semi-solid products (creams, ointments and gels) and liquids; cardiology and neurology, prescription oral dosage products; oral analgesics, both prescription and OTC, and OTC oral and nasal sprays and ophthalmic products.

Taro Canada manufactures more than 70 finished dosage form pharmaceutical products for sale in Canada and for export. It markets and distributes generic products in the local Canadian market. Its product line includes dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology, oncology, gastrointestinal and neurology: prescription oral and injects able dosage products, and allergy (antihistamine): OTC oral dosage products.

Taro U.S.A markets! and distributes generic products in the United States market. Its primary product lines include dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology and neurology: prescription oral dosage products, and other prescription and OTC products.

The Company competes with Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer/Wyeth, Valeant, Galderma, Merck/Schering-Plough, Teva Pharmaceuticals U.S.A., Mylan Laboratories, Perrigo Company, Ranbaxy Pharmaceuticals Inc., Sandoz Pharmaceuticals, Merck Canada Inc., Pfizer Canada Inc., Janssen Inc., Schering-Plough Canada, Novartis Pharmaceuticals Canada Inc., GlaxoSmithKline Inc., Bayer Inc., Bristol-Myers Squibb Canada, Apotex Inc., Teva Canada Limited, Mylan Pharmaceuticals ULC, Sandoz Canada Incorporated, Pharmascience Inc., Teva Pharmaceutical Industries Ltd., Perrigo Israel Pharmaceuticals Ltd., Dexxon Ltd., Rafa Laboratories Ltd., Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and Pfizer Inc.

Advisors' Opinion:
  • [By Ben Levisohn]

    Teva has dropped 7.7% to $37.85 today at 3:23 p.m. but doesn’t seem to be spreading though the generic drug space. Taro Pharmaceuticals (TARO) ha gained 1.1% to $79, while Actavis (ACT) has gained 1.2% to $156.25 and Dr. Reddy’s Laboratories (RDY) has advanced 1% to $40.24. Mylan (MYL) has dropped 0.7% to $38.40.

  • [By Rich Smith]

    Israeli drugmaker Taro Pharmaceutical Industries (NYSE: TARO  ) has a new CEO -- and a new Chairman of the Board, as well.

    On Thursday, Taro announced the imminent retirement of Interim Chief Executive Officer Mr. James Kedrowsk, who will be replaced August 1 by new permanent CEO Mr. Kalyanasundaram Subramanian ("Kal Sundaram"). Additionally, the company said that Dilip Shanghvi�has been appointed Chairman of its Board of Directors.

Best Biotech Companies To Invest In Right Now: BioTime Inc (BTX)

BioTime, Inc., incorporated on November 30, 1990, is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend. Its focus is to provide regenerative therapies for age-related degenerative diseases. In January 2011, the Company acquired the assets of Cell Targeting, Inc. (CTI), a biotechnology company focused on methods of painting molecules on the surface of cells, which in turn causes the cells to adhere to particular tissues, such as those afflicted with disease. On March 21, 2011, the Company acquired Glycosan BioSystems, Inc. (Glycosan) through a merger of Glycosan with OrthoCyte Corporation (OrthoCyte). Through the merger, OrthoCyte acquired all of Glycosan�� assets, including Glycosan�� Hystem hydrogel product line. In March 2011, the Company entered into an agreement with XenneX, Inc., pursuant to which it organized LifeMap Sciences, Inc. (LifeMap), a subsidiary formed to advance the development and commercialization of its human embryonic stem (hES) cell data base. In August 2011, four hES cell lines (ESI-035, ESI-049, ESI-051 and ESI-053) developed by its subsidiary ES Cell International (ESI) were approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry. In May 2012, the Company acquired XenneX, Inc., through a merger of XenneX into LifeMap Sciences. In September 2012, the Company formed a wholly owned subsidiary, BioTime Acquisition Corporation. In October 2013, Geron Corporation announced the closing of the transaction to divest the Company's stem cell assets to Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc.

HyStem is a biomaterial, which mimics the human extracellular matrix, which is the network of molecules surrounding cells in organs and tissues which is essent! ial to cellular function. Its HyStem hydrogels may have other applications when combined with the diverse and scalable cell types its scientists have isolated from hES cells. HyStem-Rx is a clinical grade formulation of HyStem-C, a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. Its subsidiary, OncoCyte Corporation, is developing PanC-Dx, a non-invasive blood-based cancer screening test designed to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check -ups. BioTime Asia, Limited (BioTime Asia) sells products for research use and may develop therapies to treat cancer and neurological and orthopedic diseases in Asia. OrthoCyte Corporation (OrthoCyte) is developing therapies to treat orthopedic disorders, diseases and injuries. ReCyte Therapeutics, Inc. (ReCyte Therapeutics) is developing therapies for age-related cardiovascular and blood disorders. Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences), is a biotechnology company focused on developing stem cell-based therapies for retinal and other neurological disorders, including the development of retinal pigment epithelial (RPE) cells for the treatment of age-related macular degeneration. LifeMap Sciences, Inc. (LifeMap) is advancing the development and commercialization of our embryonic stem cell database and plans to make the database available for the marketing of research products and for use by stem cell researchers at pharmaceutical and biotechnology companies and other institutions via paid subscriptions or on a fee per use basis.

The Company�� blood plasma expander product, Hextend, is a physiologically balanced intravenous solution used in the treatment of hypovolemia, a condition caused by low blood volume, often from blood loss during surgery or injury. Hextend maintains circulatory system fluid volume and blood pressure, and keeps vital organs perfused during surgery and t! rauma car! e. Hextend is manufactured and distributed in the United States by Hospira, Inc., and in South Korea by CJ CheilJedang (CJ), under license from it.

Human Embryonic Stem Cell Lines for Research Use

Combined with the Company�� ACTCellerate technology, it derives of a range of markets human embryonic progenitor cells (hEPCs). ESI�� six current good manufacturing practices (cGMP) hES cell lines have been approved by the NIH for inclusion in the Human Embryonic Stem Cell Registry, which renders those cell lines eligible for use in federally funded research. The ESI hES cell lines are available for purchase through www.biotimeinc.com. It also markets hEPCs developed using ACTCellerate technology. Its hEPCs are also available for sale through www.biotimeinc.com. It derived the complete genome sequence of five of the ESI hES cell lines to facilitate the development of products derived from these cell lines. It has made these GMP-grade cell lines, along with certain documentation and complete genomic deoxyribonucleic acid (DNA) sequence information, available for sale.

The Company offers human stem cell products and technology that can be used by researchers at universities and at companies in the bioscience and biopharmaceutical industries. It has developed research and clinical grade hES cell lines, which it markets for both basic research and therapeutic product development. It also markets human embryonic progenitor cell (hEPCs) developed using ACTCellerate technology. These hEPCs are purified lineages of cells, which are intermediate in the developmental process between embryonic stem cells and fully differentiated cells. The ACTCellerate cell lines are also available for purchase through http://www.biotimeinc.com.

Human Embryonic Progenitor Cells

Through the Company�� subsidiary ReCyte Therapeutics, it had a license from Advanced Cell Technology, Inc. (ACT) to use ACTCellerate technology, and the rights to market more than 200 human c! ell types! made using that process. ACTCellerate allows the rapid isolation of hEPCs, which are cells that are intermediate in the developmental process between embryonic stem cells and fully differentiated cells.

Through an agreement with ReCyte Therapeutics, Millipore Corporation became a global distributor of ACTCellerate hEPC lines. In addition to the products, which it is co-marketing with Millipore, it offers 92 other ACTCellerate hEPC lines for purchase at www.biotimeinc.com. Through its subsidiary LifeMap, it provides online biomedical database services to increase awareness of molecular markers and diverse cell types comprising its ACTCellerate hEPC lines. It also focuses to market additional cell types manufactured with its PureStem technology. PureStem cell lines are produced by the exogenous expression of specific transcription factors, which regulate the differentiation of cell types from hES or induced pluripotent stem (iPS) cells. BioTime Asia has an agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate hEPC lines and related ESpan growth media to the medical and biological research communities in China, Taiwan, Hong Kong, and Macau on an exclusive basis. The marketing agreement includes provisions for an initial stocking inventory and annual milestones to maintain exclusivity. The Company�� California Institute of Regenerative Medicine (CIRM)-funded research addresses the need for industrial scale production of purified therapeutic cells.

hES Cells Carrying Genetic Diseases

The Company focuses to add to its product line muscle progenitor cells produced from five hES cell lines carrying genes for Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, spinal muscular atrophy Type I, facioscapulohumeral muscular dystrophy 1A, and Becker muscular dystrophy. It obtained the diseased hES cell lines from Reproductive Genetics Institute (RGI).

ESpan Cell Growth Media

The Company is marketing a range of! cell-gro! wth media products called ESpan. These growth media are optimized for the growth of hEPC types. Cells need to be propagated in liquid media, in both the laboratory setting, where basic research on stem cells is performed, and in the commercial sector. Its ESpan products are marketed through Millipore and Genext.

ESpy Cell Lines

The Company focuses for development of ESpy cell lines. The ability of the ESpy cells to emit light will allow researchers to track the location and distribution of the cells in both in vitro and in vivo studies.

HyStem Hydrogel for Research and HyStem-Rx for Cell Delivery Medical Devices

HyStem is a patented biomaterial that mimics the ECM, the network of molecules surrounding cells in organs and tissues that is essential to cellular function. Its HyStem technology forms the foundation for stem cell delivery products in both the adult and embryonic stem cell marketplace, including products manufactured using its ACTCellerate technology. As an injectable product, HyStem-Rx may address need in cosmetic and reconstructive surgeries and other procedures by transplanting adipose derived cells or other adult stem cells. The transfer of cells in HyStem-Rx localizes the transplanted cells at the intended site and by providing a three-dimensional scaffold upon which cells can rebuild normal tissue. HyStem-Rx may support other emerging cell and tissue transplant therapies, such as those derived from hES and iPS cells, in addition to its potential application in the treatment of a range of conditions such as osteoarthritis, brain tumors, stroke, bone fracture, and wounds.

Advisors' Opinion:
  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company BioTime (NYSEMKT: BTX  ) has received the dreaded one-star ranking.

  • [By John Udovich]

    Stem cell stocks have not exactly been the best performers lately in part because the controversy over their use has died down over the years while major breakthroughs have been few or far between, but the industry along with small cap stem cell stocks Pluristem Therapeutics Inc (NASDAQ: PSTI), BioTime, Inc (NYSEMKT: BTX) and BioRestorative Therapies (OTCBB: BRTX) are still quietly producing their share of news or minor breakthroughs worth taking note of. Just consider the following stem cell news or news from small cap players in the sector:

Best Biotech Companies To Invest In Right Now: IsoRay Inc (ISR)

IsoRay, Inc. (IsoRay), incorporated on June 15, 2004, develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. IsoRay International LLC (International) is a wholly owned subsidiary of the Company. IsoRay obtained clearance from the Food and Drug Association (FDA) for treatment for all solid tumor applications using Cesium-131. Such applications include prostate cancer; ocular melanoma; head, neck and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer, and pancreatic cancer. The seed may be used in surface, interstitial and intracavity applications for tumors with known radio sensitivity. The Company has an existing distribution agreement with UralDial LLC (UralDial) that allows UralDial to distribute Proxcelan Cs-131 brachytherapy seeds in Russia. The Company, through UralDial, has regulatory approval to sell Cs-131 seeds in Russia.

IsoRay markets the Proxcelan Cesium-131 brachytherapy seed for the treatment of prostate cancer; lung cancer; ocular melanoma; head and neck cancers; colorectal cancer, brain cancer; and gynecological cancer. The Company focuses to market Cesium-131 for the treatment of other malignant disease, such as breast cancer, in the near future through the use of existing technologies that have received FDA-clearance. Cesium-131 is a radioactive isotope that can be produced by the neutron bombardment of Barium-130 (Ba-130). When placed into a nuclear reactor and exposed to a flux of neutrons, Ba-130 becomes Ba-131, the radioactive material that is the parent isotope of Cesium-131. The radioactive isotope Cesium-131 is normally produced by placing a quantity of stable non-radioactive barium (ideally barium enriched in isotope Ba-130) into the neutron flux of a nuclear reactor. The irradiation process converts a small fraction of this material into a radioactive form of barium (Ba-131). The Ba-131 decays by electron capture to the ! radioactive isotope of interest (Cesium-131).

As of June 30, 2011, IsoRay had agreements with several independent radiopharmacies to assay, preload, and sterilize loose seeds. During the fiscal year ended June 30, 2011, the Company loaded approximately 90% of Mick cartridges in the Company's own facility, which accounted for approximately 61% of seeds sold. Approximately 33% of seeds sold are strand configurations, including strands preloaded in needles and the remaining 6% of seeds are sold as loose seeds.

Advisors' Opinion:
  • [By James E. Brumley]

    Ugh. It's fun to be right about a stock, but it's exhausting to be too right, too fast. Case in Point? IsoRay, Inc. (NYSE: ISR). Yours truly posted some bullish comments on ISR just a couple of days ago, explaining how that day's move above a key ceiling meant a new bull trend was underway, and more gains from that price would be far easier to muster. Well, good news for those who heeded the advice - IsoRay shares are up 44% today.

  • [By Vanina Egea]

    Strengthening portfolio and business stability is to be reinforced by the introduction of new products. Last December, Textron announced the successful first flight of the Scorpion Intelligence, Surveillance and Reconnaissance (ISR)/Strike aircraft. ��he Scorpion compares very favorably to more costly aircraft currently used for low-threat missions,��pilot Dan Hinson said. The new product is expected to accommodate the budget constraints and shifting mission requirements of the US Department of Defense. The same department has granted the firm an additional contract worth $22.5 million to "deprocess" Mobile Strike Force vehicles and train the Afghan Army.

  • [By James E. Brumley]

    I hate to be the one to say I told you so, but, I told you so. Back on February 26th I suggested IsoRay, Inc. (NYSEMKT:ISR) shares were a budding breakout play. The 48% rally that's played out for ISR in the meantime unfurled right on cue. While overbought in the very short run, this small cap stock looks like it's earning the right to be compared to the likes of bigger brothers in the cancer-treatment space... names like Roche Holding Ltd. (OTCMKTS:RHHBY) or Theragenics Corporation (NYSE:TGX).

Best Biotech Companies To Invest In Right Now: Boston Therapeutics Inc (BTHE)

Boston Therapeutics, Inc. is a development-stage company. The Company�� business is the development, manufacture and commercialization of therapeutic drugs and dietary supplements with a focus on glyco-pathology, a specialized field involving understanding the importance of carbohydrates in biochemistry and progression of diseases. The Company is focusing on three products: IPOXYN, an injectable anti-hypoxia drug, which it is developing; PAZ320, which is a non-systemic, chewable drug candidate for reduction of blood glucose in diabetics in development and SUGARDOWN, a complex carbohydrate-based chewable dietary supplement, which it is marketing. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the class of carbohydrate-hydrolyzing enzyme inhibitors.

SUGARDOWN

The Company has developed SUGARDOWN, a non-systemic complex carbohydrate-based dietary supplement to moderate post-meal blood glucose using processes and technology. It has unrestricted access to both sufficient raw materials at commodity pricing and processing facilities to produce sufficient supply of SUGARDOWN to support product distribution across multiple sales channels as a dietary supplement. Its SUGARDOWN dietary supplement consists of a stabilized complex carbohydrate composition. The Company has completed development of SUGARDOWN as a dietary supplement. On January 24, 2012 the Company announced the clinical trial results in healthy volunteers performed at the University of Sydney on SUGARDOWN.

PAZ320

PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes, which release glucose from complex carbohydrate in foods during digestion, reducing the amount of available glucose absorbed through the intestine. PAZ320 is in development as a drug candidate. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the! class of carbohydrate-hydrolyzing enzyme inhibitors.

IPOXYN

The Company has developed a drug candidate product IPOXYN, a glyco-protein based therapeutic agent. Its IPOXYN anti-hypoxia drug consists of a stabilized glycoprotein composition containing oxygen-rechargeable iron, targeting both human and animal tissues and organ systems deprived of oxygen and in need of metabolic support. In addition to potential uses for human patients, it also focuses to file a registration for IPOXYN for veterinary applications under the name OXYFEX. The Company�� pharmaceutical agents are intended for intravenous administration into the circulatory system to target acute and late stage diseases.

Advisors' Opinion:
  • [By CRWE]

    Today, BTHE remains (0.00%) +0.000 at $1.10 thus far (ref. google finance Delayed: 12:25PM EDT October 10, 2013).

    Boston Therapeutics has previously closed the final tranche of approximately $1.8 million to bring total gross proceeds of approximately $5.3 million from the private placement of Common Stock and warrants to existing and new accredited investors (the “Offering”).
    Proceeds of the offering will be used to fund additional clinical trials for PAZ320, a non-systemic chewable drug designed to reduce the elevation of postprandial glucose or post-meal blood sugar for treatment of patients with Type 2 diabetes, and for general corporate purposes. PAZ320 is the first compound in a new class of therapies for this disease.

Best Biotech Companies To Invest In Right Now: Mast Therapeutics Inc (MSTX)

Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., incorporated in December 1995, is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in treating a range of diseases and conditions, such as complications arising from sickle cell disease. As of December 31, 2011, the Company also is developing ANX-514, a detergent-free formulation of the chemotherapy drug docetaxel. The Company offers ANX-188 (purified poloxamer 188), ANX-514 (docetaxel for injectable emulsion) and Exelbine (vinorelbine injectable emulsion). In April 2011, the Company acquired SynthRx, Inc. In February 2014, Mast Therapeutics Inc completed its acquisition of Aires Pharmaceuticals, Inc. Aires became a wholly-owned subsidiary of Mast Therapeutics.

ANX-188 (purified poloxamer 188)

ANX-188 is an aqueous solution of a purified form of poloxamer 188. Poloxamer 188 (P1880, is a nonionic, block copolymer that has been found to improve microvascular blood flow by reducing viscosity, particularly under low shear conditions, and by reducing adhesive frictional forces. The Company�� purified form of P188 (purified P188), which is the active ingredient in ANX-188, was designed to eliminate certain low molecular weight substances present in P188 (non-purified), which is primarily responsible for the moderate to moderately severe elevations in serum creatinine levels (acute renal dysfunction) observed in prior clinical studies of P188 (non-purified). Purified P188 has been evaluated in multiple clinical studies by a prior sponsor, including a 255-patient, phase III study.

ANX-514 (docetaxel for injectable emulsion)

ANX-514 is a detergent-free emulsion formulation of docetaxel, an intravenously-injected chemotherapy drug commonly used to treat solid tumors. Taxotere, a branded form! ulation of docetaxel, is approved to treat breast, non-small cell lung, prostate, gastric, and head and neck cancers. ANX-514 was designed to have clinically comparable release of docetaxel relative to Taxotere while eliminating the presence of polysorbate 80 and ethanol, both of which are used to solubilize docetaxel in the Taxotere formulation. The ANX-514 formulation solubilizes docetaxel using oil droplets consists of a combination of non-toxic excipients. Docetaxel is contained within these oil droplets and can be administered intravenously without using detergents as pharmaceutical vehicles. Once in central circulation, the emulsion is metabolized rapidly, leaving chemically-identical active ingredient to exert its cytotoxic effect. ANX-514 may reduce the incidence and severity of hypersensitivity reactions and delay the onset of fluid retention.

Exelbine (vinorelbine injectable emulsion)

Exelbine is an emulsion formulation of the chemotherapy drug vinorelbine. Navelbine, a branded formulation of vinorelbine, is approved in the United States to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, and approved in the European Union to treat non-small cell lung cancer and advanced or metastatic breast cancer.

In August 2011, the Company received a complete response letter from the Food and Drug Administration (FDA) stating that it could not approve the Exelbine Non Disclosure Agreement (NDA) in its present form and that the bioequivalence study would need to be repeated because the authenticity of the drug products used in the bioequivalence trial could not be verified in accordance with FDA standards. However, the Company elected to discontinue independent development of Exelbine and as of December 31, 2011, the Company was seeking a partner or outside investor for the program to complete the necessary bioequivalence study.

The Company competes with GlaxoSmithKline, Provenge and Pfizer.

Advisors' Opinion:
  • [By Lauren Pollock]

    Mast Therapeutics Inc.(MSTX) said the U.S. Food and Drug Administration gave orphan-drug designation to its MST-188 drug for the treatment of acute limb ischemia, providing a boost for the biopharmaceutical firm. Shares surged.

  • [By John Udovich]

    The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

  • [By James E. Brumley]

    A little over a month ago, owning Mast Therapeutics, Inc. (NYSE: MSTX) was nothing but pure misery. Shares plunged from $0.63 to $0.43 in one day, when details of a dilutive public offering were unveiled. As is so often the case though, the market may have overshot with the selling effort that KO's MSTX. Though putting more shares 'out there' mathematically meant existing shareholders would have to share more of the company's upside with newcomers, what's slowly coming to light is that the inflow of new cash is still more advantageous to those prior shareholders; the company would progress little without it.

Best Biotech Companies To Invest In Right Now: ViroPharma Incorporated(VPHM)

ViroPharma Incorporated, a biotechnology company, develops and commercializes therapeutic products that address serious diseases in the United States and internationally. It focuses on developing products used by physician specialists or in hospital settings. The company markets and sells Cinryze, a C1 esterase inhibitor therapy for the routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema, a life-threatening genetic disorder; and Vancocin HCl capsule, an oral capsule formulation for the treatment of C. difficile-associated diarrhea (CDAD) and to treat enterocolitis caused by staphylococcus aureus, including methicillin-resistant strains. It also offers Plenadren, an orphan drug for treatment of adrenal insufficiency in adults; Buccolam, a oromucosal solution for treatment of prolonged, acute, and convulsive seizures in infants, toddlers, children, and adolescents; and maribavir, an antiviral compound for the treatment o f CMV disease through a license agreement with GlaxoSmithKline. The company?s primary development programs include Cinryze, a C1 esterase inhibitor for management of hereditary angioedema; and VP 20621, a non-toxigenic strain of C. difficile. Its clinical stage drug candidate comprises VP-20629 for the treatment of Friedreich?s Ataxia. The company sells its products directly to wholesale drug distributors and specialty pharmacies/distributors. ViroPharma Incorporated was founded in 1994 and is headquartered in Exton, Pennsylvania.

Advisors' Opinion:
  • [By Max Macaluso and David Williamson]

    At the end of last week, a Bloomberg article revealed that Shire (NASDAQ: SHPG  ) and pharmaceutical giant Sanofi� (NYSE: SNY  ) may be circling ViroPharma� (NASDAQ: VPHM  ) . The the following video, from The Motley Fool's health care show Market Checkup, analysts David Williamson and Max Macaluso take a close look at ViroPharma and discuss the recent interest in this small biotech company.